Skip to content

Ketamine Alters Tuning of Neural and Behavioral Spatial Working Memory Precision

Masih Rahmati, Flora Moujaes, Nina Purg Suljič, Jie Lisa Ji, Lucie Berkovitch, Kangjoo Lee, Clara Fonteneau, Charles Schleifer, Brendan Adkinson, Aleksandar Savič, Nicole Santamauro, Zailyn Tamayo, Caroline Diehl, Antonija Kolobaric, Morgan Flynn, Terry Camarro, Clayton E. Curtis, Grega Repovš, Sarah K. Fineberg, Peter T Morgan, Katrin H. Preller, John H. Krystal, John D. Murray, Youngsun T. Cho, Alan Anticevic

bioRxiv Preprint Server February 10, 2025 preprint DOI: 10.1101/2025.02.10.637233 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pharmacological fMRI study
Population Healthy humans
Intervention Ketamine
Topics Esketamine Ketamine
Keywords Memory deficits:memory problems Poorer memory Memory impairment Memory loss Spatial tuning Neural precision Brain function Brain circuit disruptions Brain disorders:neurological conditions Cognitive disorders Neuropharmacology:drug effects Psychopharmacology Cognitive modulators Neuroimaging:brain imaging FMRI Brain scans
Citations 1
Key points Ketamine broadens neural spatial tuning, attenuates activation across multiple brain regions, and worsens spatial working memory performance in healthy humans.

Abstract

Deficits in working memory (WM) are a hallmark of neuropsy-chiatric disorders such as schizophrenia, yet their neurobiological basis remains poorly understood. Glutamate N-methyl-D-aspartate receptors (NMDARs) are critical for spatial WM (sWM), with NMDAR antagonist ketamine known to attenuate task-evoked activation and reduce sWM accuracy. Cortical microcircuit models hypothesize that NMDAR antagonism impairs sWM by broadening neural spatial tuning, but this mechanism has not been directly tested in humans. Using a pharmacological fMRI approach, we showed how ketamine broadened neural spatial tuning, attenuated activation across visual, parietal, and frontal areas, and worsened sWM performance in healthy humans. Ketamine-induced changes in tuning were more consistent across individuals and brain regions than changes in overall activation and correlated with individual differences in sWM performance. These findings provide empirical evidence linking NMDAR antagonism to disruptions in cortical microcircuit dynamics, the resulting neural tuning alterations, and sWM impairments, advancing frameworks for therapeutic development.

Comparable studies

Other experimental studies on ketamine, most cited first.

Study Year Design Participants
Ketamine activates psychosis and alters limbic blood flow in schizophrenia Schizophrenic individuals 1995 Experimental study
The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine Healthy participants 2019 Controlled experimental study n = 15
Ketamine Increases Human Motor Cortex Excitability to Transcranial Magnetic Stimulation Normal human subjects 2003 Experimental study n = 7
Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans Human participants 2015 Experimental study
S(+)-ketamine Effect on Experimental Pain and Cardiac Output Healthy adult volunteers (10 men and 10 women) 2009 Pharmacokinetic-pharmacodynamic modeling study in healthy volunteers n = 20

Citations in the library

Explore topics